95 related articles for article (PubMed ID: 18045827)
1. Association of functional haem oxygenase-1 gene promoter polymorphism with polycystic kidney disease and IgA nephropathy.
Courtney AE; McNamee PT; Heggarty S; Middleton D; Maxwell AP
Nephrol Dial Transplant; 2008 Feb; 23(2):608-11. PubMed ID: 18045827
[TBL] [Abstract][Full Text] [Related]
2. Influence of the endothelial nitric oxide synthase polymorphism on the progression of autosomal dominant polycystic kidney disease and IgA nephropathy.
Merta M; Reiterová J; Tesar V; Stekrová J; Viklický O
Ren Fail; 2002 Jul; 24(4):467-75. PubMed ID: 12212826
[TBL] [Abstract][Full Text] [Related]
3. Influence of the endothelial nitric oxide synthase polymorphism on the progression of autosomal dominant polycystic kidney disease and IgA nephropathy.
Merta M; Reiterová J; Tesar V; Stekrová J; Viklický O
Ren Fail; 2002 Sep; 24(5):585-93. PubMed ID: 12380903
[TBL] [Abstract][Full Text] [Related]
4. The heme oxygenase-1 genotype is a risk factor to renal impairment of IgA nephropathy at diagnosis, which is a strong predictor of mortality.
Chin HJ; Cho HJ; Lee TW; Na KY; Yoon HJ; Chae DW; Kim S; Jeon US; Do JY; Park JW; Yoon KW; Shin YT; Lee KW; Na KR; Cha DR; Kang YS;
J Korean Med Sci; 2009 Jan; 24 Suppl(Suppl 1):S30-7. PubMed ID: 19194559
[TBL] [Abstract][Full Text] [Related]
5. Association of functional heme oxygenase-1 gene promoter polymorphism with renal transplantation outcomes.
Courtney AE; McNamee PT; Middleton D; Heggarty S; Patterson CC; Maxwell AP
Am J Transplant; 2007 Apr; 7(4):908-13. PubMed ID: 17391133
[TBL] [Abstract][Full Text] [Related]
6. A meta-analysis of the association between angiotensin-converting enzyme insertion/deletion gene polymorphism and end-stage renal disease risk in IgA nephropathy patients.
Zhou TB; Yin SS; Liang R
J Renin Angiotensin Aldosterone Syst; 2013 Sep; 14(3):235-41. PubMed ID: 23060471
[TBL] [Abstract][Full Text] [Related]
7. GT-repeat polymorphism in the heme oxygenase-1 gene promoter is associated with cardiovascular mortality risk in an arsenic-exposed population in northeastern Taiwan.
Wu MM; Chiou HY; Chen CL; Wang YH; Hsieh YC; Lien LM; Lee TC; Chen CJ
Toxicol Appl Pharmacol; 2010 Nov; 248(3):226-33. PubMed ID: 20708634
[TBL] [Abstract][Full Text] [Related]
8. Association between the heme oxygenase-1 promoter polymorphism and renal transplantation outcome in Greece.
Katana E; Skoura L; Giakoustidis D; Takoudas D; Malisiovas N; Daniilidis M
Transplant Proc; 2010 Sep; 42(7):2479-85. PubMed ID: 20832528
[TBL] [Abstract][Full Text] [Related]
9. Heme oxygenase-1 gene promoter polymorphism is associated with risk of gastric adenocarcinoma and lymphovascular tumor invasion.
Lo SS; Lin SC; Wu CW; Chen JH; Yeh WI; Chung MY; Lui WY
Ann Surg Oncol; 2007 Aug; 14(8):2250-6. PubMed ID: 17520317
[TBL] [Abstract][Full Text] [Related]
10. Chronic kidney disease progression to end stage renal disease: a single center experience of the role of the underlying kidney disease.
Ekart R; Ferjuc A; Furman B; Gerjevič Š; Bevc S; Hojs R
Ther Apher Dial; 2013 Aug; 17(4):363-7. PubMed ID: 23931872
[TBL] [Abstract][Full Text] [Related]
11. A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with risk for melanoma.
Okamoto I; Krögler J; Endler G; Kaufmann S; Mustafa S; Exner M; Mannhalter C; Wagner O; Pehamberger H
Int J Cancer; 2006 Sep; 119(6):1312-5. PubMed ID: 16596642
[TBL] [Abstract][Full Text] [Related]
12. Length polymorphism in heme oxygenase-1 is associated with arteriovenous fistula patency in hemodialysis patients.
Lin CC; Yang WC; Lin SJ; Chen TW; Lee WS; Chang CF; Lee PC; Lee SD; Su TS; Fann CS; Chung MY
Kidney Int; 2006 Jan; 69(1):165-72. PubMed ID: 16374439
[TBL] [Abstract][Full Text] [Related]
13. CC-chemokine receptor five gene polymorphism in primary IgA nephropathy: the 32 bp deletion allele is associated with late progression to end-stage renal failure with dialysis.
Berthoux FC; Berthoux P; Mariat C; Thibaudin L; Afiani A; Linossier MT
Kidney Int; 2006 Feb; 69(3):565-72. PubMed ID: 16395252
[TBL] [Abstract][Full Text] [Related]
14. Haem oxygenase-1 genotype and cardiovascular adverse events in patients with peripheral artery disease.
Dick P; Schillinger M; Minar E; Mlekusch W; Amighi J; Sabeti S; Schlager O; Raith M; Endler G; Mannhalter C; Wagner O; Exner M
Eur J Clin Invest; 2005 Dec; 35(12):731-7. PubMed ID: 16313248
[TBL] [Abstract][Full Text] [Related]
15. G protein beta3 subunit C825T polymorphism in primary IgA nephropathy.
Thibaudin L; Berthoux P; Thibaudin D; Mariat C; Berthoux F
Kidney Int; 2004 Jul; 66(1):322-8. PubMed ID: 15200440
[TBL] [Abstract][Full Text] [Related]
16. HO-1 promoter polymorphism associated with rheumatoid arthritis.
Rueda B; Oliver J; Robledo G; López-Nevot MA; Balsa A; Pascual-Salcedo D; González-Gay MA; González-Escribano MF; Martín J
Arthritis Rheum; 2007 Dec; 56(12):3953-8. PubMed ID: 18050210
[TBL] [Abstract][Full Text] [Related]
17. Microsatellite polymorphism in the heme oxygenase-1 gene promoter and cardiac allograft vasculopathy.
Ullrich R; Exner M; Schillinger M; Zuckermann A; Raith M; Dunkler D; Horvat R; Grimm M; Wagner O
J Heart Lung Transplant; 2005 Oct; 24(10):1600-5. PubMed ID: 16210136
[TBL] [Abstract][Full Text] [Related]
18. Favorable outcome of renal transplantation in patients with IgA nephropathy.
Andresdottir MB; Hoitsma AJ; Assmann KJ; Wetzels JF
Clin Nephrol; 2001 Oct; 56(4):279-88. PubMed ID: 11680657
[TBL] [Abstract][Full Text] [Related]
19. Impact of interferon-gamma and interleukin-4 gene polymorphisms on development and progression of IgA nephropathy in Japanese patients.
Masutani K; Miyake K; Nakashima H; Hirano T; Kubo M; Hirakawa M; Tsuruya K; Fukuda K; Kanai H; Otsuka T; Hirakata H; Iida M
Am J Kidney Dis; 2003 Feb; 41(2):371-9. PubMed ID: 12552499
[TBL] [Abstract][Full Text] [Related]
20. The effect of a promoter polymorphism in the heme oxygenase-1 gene on the risk of ischaemic cerebrovascular events: the influence of other vascular risk factors.
Funk M; Endler G; Schillinger M; Mustafa S; Hsieh K; Exner M; Lalouschek W; Mannhalter C; Wagner O
Thromb Res; 2004; 113(3-4):217-23. PubMed ID: 15140586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
